Table 3.
Type of Infection | Overall Sample (n = 9,403) | Participants Without Prevalent CVD at Baseline (n = 8,337) | ||||||
---|---|---|---|---|---|---|---|---|
No. of Events | Prevalent CVD at Baseline (No vs. Yes) | No. of Events | hs-cTnT Concentration, per log(hs-cTnT) | NT-proBNP Concentration, per log(NT-proBNP) | ||||
HR | 95% CI | HR | 95% CI | HR | 95% CI | |||
Pneumonia | 1,150 | 1.40 | 1.18, 1.66 | 929 | 1.32 | 1.17, 1.49 | 1.08 | 1.01, 1.16 |
Urinary tract infection | 1,137 | 1.31 | 1.10, 1.57 | 964 | 1.23 | 1.09, 1.39 | 1.14 | 1.06, 1.22 |
Bloodstream infection | 670 | 1.28 | 1.02, 1.61 | 554 | 1.34 | 1.15, 1.56 | 1.13 | 1.04, 1.24 |
Cellulitis | 416 | 1.31 | 0.99, 1.74 | 339 | 1.56 | 1.29, 1.88 | 1.19 | 1.06, 1.34 |
Abbreviations: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; hs-cTnT, high-sensitivity cardiac troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide.